Along With All NDAs Submitted To US FDA In FY2023, Costs For OTC Switch Proposals Increase

Agency publishes Prescription Drug User Fee Act rates for FY2023, the first of five covered in reauthorization of program Congress approved on 30 September as legislation added to a continuing resolution to fund federal agencies through 16 December.